Infectious bursal disease (IBD) is one of the most contagious viral and immunosuppressive diseases in young chickens. Vaccination at proper time is the only way to control the disease. In Pakistan, however, the development of an efficacious and economical vaccine is a major issue. The objective of the study was, therefore, to develop an effectual and inexpensive vaccine. In total, 300 birds were divided into six groups (A to F), each of 50 birds and inoculated subcutaneously on 10th day of age. Three different passaged virus (8, 16 and 24), field isolate and commercial IBD vaccine were tested. The gross pathological and histopathological changes were recorded for bursa, thymus, muscles and kidney. The serum samples were collected for antibody titration against IBDV. Significant changes including swelling and hemorrhages started at 48th h to 10th day post inoculation (PI) in group receiving commercial vaccine, whereas group with inoculation schedule of 24th passage showed very low bursal lesion with regards to the control group. Greater bursa body weight ratio was observed in the group receiving commercial vaccine compared with the one units field isolate and the one units 8th passage, whereas it decreased in groups with 16th and 24th passage. The titre of virus was high in the groups with field isolates and that of 8th passage, whereas group with commercial vaccine and 24th passage had moderate titre with respect to other groups. Bursal changes were minimal in all groups except for group with 24th passage, where no changes were found at 24 h PI relative control group. There were no histopathological changes in the muscles, kidney and thymus in the 24th passage group E respect to all other groups. Greater antibody titer and highest (100%) protection against disease was observed in this group with regard to other groups. On the basis of our results, 24th passage virus can be used to protect the birds from IBD.